XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock Outstanding [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2020 8,885,797            
Balance at Dec. 31, 2020   $ 89 $ 15,836 $ (1,639) $ (140) $ 30,005 $ 44,151
Common stock repurchased* (in shares) [1] (70,947)            
Common stock repurchased* [1]       (2,712)     (2,712)
Stock options exercised (in shares) 67,500            
Stock options exercised   1 106       107
Net income             1,040
Stock compensation expense     57       57
Foreign currency translation adjustment         4   4
Balance (in shares) at Mar. 31, 2021 8,882,350            
Balance at Mar. 31, 2021   90 15,999 (4,351) (136) 31,045 42,647
Balance (in shares) at Dec. 31, 2020 8,885,797            
Balance at Dec. 31, 2020   89 15,836 (1,639) (140) 30,005 44,151
Net income             3,845
Stock compensation expense [1]             198
Balance (in shares) at Jun. 30, 2021 8,742,599            
Balance at Jun. 30, 2021   90 16,197 (9,399) (132) 33,850 40,606
Balance (in shares) at Mar. 31, 2021 8,882,350            
Balance at Mar. 31, 2021   90 15,999 (4,351) (136) 31,045 42,647
Common stock repurchased* (in shares) [1] (144,194)            
Common stock repurchased* [1]       (5,048)     (5,048)
Net income           2,805 2,805
Foreign currency translation adjustment         4   4
Stock compensation expense (in shares) [1] 4,443            
Stock compensation expense [1]     198        
Balance (in shares) at Jun. 30, 2021 8,742,599            
Balance at Jun. 30, 2021   90 16,197 (9,399) (132) 33,850 40,606
Balance (in shares) at Dec. 31, 2021 8,689,815            
Balance at Dec. 31, 2021   90 16,261 (11,327) (194) 39,044 43,874
Common stock repurchased* (in shares) [1] (70,864)            
Common stock repurchased* [1]       (2,332)     (2,332)
Net income         8,670   8,670
Stock compensation expense     10       10
Foreign currency translation adjustment         1   1
Balance (in shares) at Mar. 31, 2022 8,618,951            
Balance at Mar. 31, 2022   90 16,271 (13,659) (193) 47,714 50,223
Balance (in shares) at Dec. 31, 2021 8,689,815            
Balance at Dec. 31, 2021   90 16,261 (11,327) (194) 39,044 $ 43,874
Stock options exercised (in shares)             0
Net income             $ 11,526
Balance (in shares) at Jun. 30, 2022 8,567,008            
Balance at Jun. 30, 2022   90 16,421 (15,006) 50 50,570 52,125
Balance (in shares) at Mar. 31, 2022 8,618,951            
Balance at Mar. 31, 2022   90 16,271 (13,659) (193) 47,714 50,223
Common stock repurchased* (in shares) [1] (58,447)            
Common stock repurchased* [1]       (1,347)     $ (1,347)
Stock options exercised (in shares)             0
Net income           2,856 $ 2,856
Foreign currency translation adjustment         243   243
Stock compensation expense (in shares) 6,504            
Stock compensation expense     150       150
Balance (in shares) at Jun. 30, 2022 8,567,008            
Balance at Jun. 30, 2022   $ 90 $ 16,421 $ (15,006) $ 50 $ 50,570 $ 52,125
[1] At June 30, 2022, approximately $19,994,000 was authorized for future repurchases of our common stock.